Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 81.57
-0.21 (-0.26%)
At close: Dec 5, 2025
Xiamen Amoytop Biotech Revenue
Xiamen Amoytop Biotech had revenue of 968.93M CNY in the quarter ending September 30, 2025, with 26.68% growth. This brings the company's revenue in the last twelve months to 3.34B, up 28.77% year-over-year. In the year 2024, Xiamen Amoytop Biotech had annual revenue of 2.82B with 34.13% growth.
Revenue (ttm)
3.34B
Revenue Growth
+28.77%
P/S Ratio
9.96
Revenue / Employee
1.38M
Employees
2,423
Market Cap
33.30B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |